Taken together, our study unveiled the molecular mechanism of GRHL1 in regulating cell cycle progression and clarified the upstream signaling pathway that activated GRHL1, which provided a theoretical basis for GRHL1 as a potential drug target for NSCLC treatment. Here, GRHL1 is linked to non-small cell lung carcinoma.